Status:
UNKNOWN
Outcomes Data of Adipose Stem Cells to Treat Osteoarthritis
Lead Sponsor:
StemGenex
Conditions:
Osteoarthritis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the impact that treatment with a cellular concentrate derived from an individual's own fat, known as the stromal vascular fraction (SVF), has on joint pain an...
Eligibility Criteria
Inclusion
- Fluent in English
- Over the age of 18
- Diagnosed with OA of the knee and/or hip
- Scheduled for intravenous and intra-articular administrations of autologous SVF
- Capable of understanding and willing to sign informed consent
- Willing and able to complete brief phone interviews
- Willing and able to complete online surveys
Exclusion
- Co-morbidity with an autoimmune disorder
- Pregnant, may become pregnant, or breastfeeding
- Subjects for which baseline data is not available
Key Trial Info
Start Date :
September 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02241408
Start Date
September 1 2014
End Date
September 1 2019
Last Update
August 31 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
StemGenex
San Diego, California, United States, 92121